Revisiting the markers interleukin-6 and glucagon-like peptide-1 for targeting low-grade inflammation in type 2 diabetes: a meta-analysis and our lab experience.
重新探討白介素-6和胰高血糖素樣肽-1作為針對2型糖尿病低度炎症的標記物:一項綜合分析及我們的實驗室經驗。
Acta Diabetol 2024-10-30
Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study.
Adiponectin 可能在 2 型糖尿病患者接受 GLP-1RAs 治療的代謝效應中扮演關鍵角色:一項初步的縱向研究。
Endocrine 2024-11-09
Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1.
人類受試者在胰島素細胞功能和葡萄糖耐受性受損的情況下,具有較高水平的胰島內完整 GLP-1。
Metabolism 2024-12-03
Plasma Glucagon-Like Peptide-1 Levels in Nigerians with Newly Diagnosed Type 2 Diabetes Mellitus: A Cross-Sectional Study.
尼日利亞新診斷的第二型糖尿病患者血漿胰高血糖素樣肽-1水平:一項橫斷面研究。
West Afr J Med 2025-02-26
Inflammation levels in type 2 diabetes mellitus patients with mild cognitive impairment: Assessment followed by amelioration via dapagliflozin therapy.
2型糖尿病患者輕度認知障礙的炎症水平:通過 dapagliflozin 治療的評估與改善。
J Diabetes Complications 2025-04-14
The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta-analysis.
GLP-1 受體促效劑對第二型糖尿病患者循環發炎指標的影響:系統性回顧與統合分析
Diabetes Obes Metab 2025-04-15
Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications.
Pentraxin-3 作為糖尿病的生物標記:對發炎、血管併發症及抗糖尿病藥物調節作用的深入探討
Biomedicines 2025-04-29
Role of Residual Inflammation as a Risk Factor Across Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Unpacking the Burden in People with Type 2 Diabetes.
心血管-腎臟-代謝(CKM)症候群中殘餘性發炎作為風險因子的角色:剖析第二型糖尿病患者的負擔
Diabetes Ther 2025-05-09
Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans.
GIP/GLP-1 分泌比例改變與人類 β 細胞功能受損相關
J Clin Endocrinol Metab 2025-05-12
Proinflammatory cytokine-induced alpha cell impairment in human islet microtissues is partially restored by dual incretin receptor agonism.
人類胰島微組織中由促發炎細胞激素引起的α細胞功能障礙可部分被雙重腸促素受體激動劑所恢復
Diabetologia 2025-05-15